Skip to content
healthcare.dev

OSELTAMIVIR PHOSPHATE

NDC 69315-174, OSELTAMIVIR PHOSPHATE, suspension, from Leading Pharma, LLC.

Product NDC
69315-174
Status
Listed
Labeler
Leading Pharma, LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214949
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69315-174 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OSELTAMIVIR PHOSPHATE6 mg/mL

Pharmacologic classes

Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]

Package NDCNDC-11Package
69315-174-606931501746060 mL in 1 BOTTLE (69315-174-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ef093e4d-5b1a-463f-a1a3-b795a4387a81

Use it

Look up 69315-174 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69315-174 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69315-174. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.